MediWound Ltd. (Nasdaq: MDWD), which has developed and markets a burn treatment compound that is undergoing clinical trials for the treatment of wounds, announced it has raised $30 million. The collection was at market price. Investors include New Era Capital Partners, Deep Insight, IBF and Discount Capital.